Future research directions based on SLFN11 should focus on the selection of evaluation methods, dynamic monitoring technology, optimization of combination therapy, elucidation of molecular mechanisms, cross-cancer validation, and regulation of the immune microenvironment. Here, SLFN11 is linked to cancer.